[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100492560":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":7,"responsibleParty":19,"collaborators":7,"id":23,"slug":24,"hasResults":25,"nctId":26,"briefTitle":27,"officialTitle":27,"acronym":7,"eligibilityCriteria":28,"healthyVolunteers":25,"sex":29,"minAge":30,"maxAge":7,"enrollmentInfo":31,"targetDuration":7,"studyType":34,"phases":7,"briefSummary":35,"conditions":36,"keywords":7,"overallStatus":38,"whyStopped":7,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","pleural markers","Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Mona Adel Mostafa, Master","CONTACT","01124629683","maiadel9995@gmail.co",{"type":20,"investigatorFullName":21,"investigatorTitle":22,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Mona Adel","Doctor","100492560","cancer-ratiopleural-fluid-adenosine-deaminaselactate-dehydrogenase-interferony-tumor-necrosis-factorand-interleukins21218for-differentiation-between-malignant-and-non-malignant-pleural-effusion-100492560",false,"NCT05693727","Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion","Inclusion Criteria:\n\n* Patients (100 cases) with exudative pleural effusion who will be admitted to Department of Chest diseases and Tuberculosis, Assiut University Hospital\n\nExclusion Criteria:\n\n* Age ˂ 18 years\n* Refusal to participate in the study","ALL","18 Years",{"count":32,"type":33},100,"ESTIMATED","OBSERVATIONAL","To evaluate the ability of cancer ratio and pleural fluid markers to discriminate between malignant and non malignant effusion",[37],"Pleural Effusion, Malignant","NOT_YET_RECRUITING","2023-01-20",{"date":41,"type":42},"2023-01-23","ACTUAL",{"date":44,"type":33},"2023-09-01",{"date":46,"type":33},"2027-09-01",{"name":5,"class":6}]